Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Hackers contacted employees at financial and healthcare organizations over Microsoft Teams to trick them into granting remote ...

Hackers are impersonating IT staff in Microsoft Teams to trick employees into installing malware, giving attackers stealthy access to corporate networks.

Ethereum co-founder Vitalik Buterin laid out a quantum resistance roadmap targeting four key vulnerabilities in the network’s cryptography.

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

Oracle-based quantum algorithms cannot use deep loops because quantum states exist only as mathematical amplitudes in Hilbert space with no physical substrate. Criticall ...

Using the right study materials can help strengthen the skills required to crack technical interviews in 2026. They aid in strengthening problem-solving skills, ...

Vitalik maps out quantum risks as Ethereum Strawmap outlines seven forks to strengthen post-quantum security, scalability, and finality.